We are live on ! Find out more
KALV

KalVista Pharmaceuticals

Delisted

KALV was delisted on the 10th of June, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
SHI
1
SV Health Investors
Massachusetts
$52.4M -$15.5M -716,654 -28%
RCM
2
RA Capital Management
Massachusetts
$41.2M
VC
3
Vivo Capital
California
$38.9M
PC
4
Polar Capital
United Kingdom
$32.9M +$23.2M +1,070,300 +1,357%
VMI
5
VHCP Management III
New York
$27.8M -$6.81M -314,301 -24%
EAM
6
Eventide Asset Management
Massachusetts
$25.8M
Fidelity Investments
7
Fidelity Investments
Massachusetts
$21M +$15.9M +735,014 New
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$19M +$1.41M +65,000 +11%
DM
9
Deerfield Management
New York
$18.6M
VMI
10
VHCP Management II
New York
$16.4M -$4.03M -185,699 -24%
GTC
11
Ghost Tree Capital
New York
$11.4M -$542K -25,000 -6%
IVM
12
InterWest Venture Management
California
$11.1M
Vanguard Group
13
Vanguard Group
Pennsylvania
$10.2M +$359K +16,547 +5%
Invesco
14
Invesco
Georgia
$8.98M +$808K +37,268 +13%
IBT
15
International Biotechnology Trust
United Kingdom
$6.06M -$2.31M -106,383 -33%
ACP
16
Acuta Capital Partners
California
$5.88M +$705K +32,500 +19%
BC
17
Boxer Capital
California
$5.72M
Renaissance Technologies
18
Renaissance Technologies
New York
$4.58M -$418K -19,300 -11%
SB
19
Samsara BioCapital
California
$3.39M -$683K -31,500 -21%
Millennium Management
20
Millennium Management
New York
$2.76M +$2.09M +96,470 New
O
21
OrbiMed
New York
$2.59M +$1.96M +90,500 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$2.38M -$17K -786 -0.9%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$2.08M +$1.33M +61,414 +552%
FI
24
Fosun International
China
$2.03M -$1.41M -64,837 -47%
BlackRock
25
BlackRock
New York
$2.01M +$546K +25,179 +56%